Speaker

Martin Brenner

Chief Executive & Scientific Officer, iBio

Martin Brenner, Chief Executive & Scientific Officer, iBio, is speaking at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Unlocking Superior Obesity Outcomes by Preserving Muscle While Maximizing Fat Loss”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Obesity & Weight Loss Drug Development Summit Europe
28–29 Oct 2026Munich, Germany
- SpeakerUnlocking Superior Obesity Outcomes by Preserving Muscle While Maximizing Fat Loss

More speakers at 2nd Obesity & Weight Loss Drug Development Summit Europe

Anna Altieri
Translational Research Associate, Resalis Therapeutics
Henrik Bjork Hansen
Director - Scientific, Gubra
Steffen-Sebastian Bolz
Executive Board Member and Chief Scientific Officer, APHAIA Pharma AG
Daniel de la Torre
VP of Research & Development, Constructive Bio
Mélanie Flaender
Head of Project Management, Cytoo
Lora Heisler
Professor, University of Aberdeen

See all 19 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Martin Brenner, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].